Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present. 

 

Leonard Weinstock, MD - Celiac Disease (2017 Conference) (LDN, low dose naltrexone)

Celiac disease is a remarkable condition. It can present in so many different ways and have so many symptoms. What we're going to try is to hone down on the autoimmune conditions that are associated with it, which don't get as much attention in the literature as they should.

 

Leonard Weinstock, MD - POTS and Mast Cell Activation Syndromes (2017 Conference) (LDN, low dose naltrexone)

Dr Leonard Weinstock is from St Louis in Missouri and helps patients with GI Issues and other autoimmune conditions.

 

Kent Holtorf, MD - CFS/ME and Fibromyalgia (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Holtorf's CFS/ME Presentation

 

“Skip” Lenz, PharmD - Report on LDN Study (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Lenz's LDN Study Presentation

“Report on the Longitudinal Study of the Effects, Side Effects & Interaction of Naltrexone in Low Dose”. 

 

Kent Holtorf, MD - Immune Modulatory Treatments for Chronic Illness (2018 Conference) (LDN, low dose naltrexone)